Delivery Order SPE2DE23D0008-SPE2D625F4GUV
- Not listed
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order for Natrelle Inspira SCM 330cc breast implants by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2025. This delivery order, which has no set-aside designation, is a child contract stemming from one of Allergan's larger Indefinite Delivery Vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022. The order is...
- The U.S. Department of Defense Medical Supply Chain division awarded a $2,814.00 fixed-price delivery order to Allergan USA Inc. (a subsidiary of AbbVie Inc.) on May 30, 2025, for Natrelle Inspira SCF 385CC breast implants with an ultimate completion date of May 30, 2025. The delivery order will be performed in Irvine, California, and includes economic price adjustment provisions. This award was made without a set-aside designation, reflecting Allergan's status as the sole source for this...
- The U.S. Department of Defense Medical Supply Chain, operating through the Defense Logistics Agency Troop Support Medical, awarded a $2,814 fixed-price delivery order with economic price adjustment to Allergan USA Inc. for Natrelle Inspira SCX 800cc breast implants. The delivery order, issued on September 11, 2025, with an ultimate completion date of September 25, 2025, represents a child order under one of Allergan's existing Indefinite Delivery Vehicles—specifically a $13.5 million IDV for...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Medical Supply Chain division of the Defense Logistics Agency on July 24, 2025, for Natrelle Inspira SSM 445CC breast implants. This fixed-price delivery order with economic price adjustment represents a child award issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical implants to the federal government. The order is scheduled...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,607.00 fixed-price delivery order to Allergan USA Inc. on September 15, 2025, for Natrelle Inspira SCM 520CC breast implants. The delivery order, which has no set-aside designation, represents a child award under one of Allergan's two significant Indefinite Delivery Vehicles with DLA Troop Support Medical—specifically the $13.5 million IDV for Natrelle breast implants and surgical devices established on December 8, 2022. Allergan USA...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $5,421.00 fixed-price delivery order contract by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, for Natrelle Inspira SSM 210CC breast implants. The contract, which carries an ultimate completion date of July 23, 2025, will be performed at Allergan's facility in Irvine, California. This delivery order was awarded without set-aside designation, reflecting Allergan's status as the sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,092.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division for Inspira SRLP 205CC breast implants. The award, made on September 11, 2025, with an ultimate completion date of September 22, 2025, represents a child delivery order under one of Allergan's larger Indefinite Delivery Vehicle contracts for Natrelle breast implants and surgical devices valued at $13.5 million. The contract utilizes...
- SPE2DE23D0008Indefinite Delivery Contract
- SPE2DE23D0008-SPE2D625F4GUVDelivery Order
Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order on September 11, 2025, for Natrelle Inspira SCX 495CC breast implants, with a completion date of September 15, 2025. The contract was awarded without a set-aside designation and is being performed in Irvine, California. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain division, which oversees procurement of specialized medical devices for the Department of Defense and related federal healthcare systems. This award represents a child delivery order under Allergan's larger Indefinite Delivery Vehicle contracts with DLA Troop Support Medical, including a $13.5 million IDV for Natrelle breast implants and surgical devices established in December 2022. Allergan serves as the primary supplier of specialized breast implant products to military treatment facilities, Veterans Affairs hospitals, and Indian Health Service centers, supporting reconstructive and aesthetic surgical procedures across the federal healthcare enterprise. The fixed-price structure with economic price adjustment reflects the standardized nature of these critical medical supply orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/11/25 |